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Abstract
The emerging field of nano-biology is borne from advances in our ability to control the structure of materials
on finer and finer length-scales, coupled with an increased appreciation of the sensitivity of living cells to
nanoscale topographical, chemical and mechanical cues. As we envisage and prototype nanostructured
bioelectronic devices there is a crucial need to understand how cells feel and respond to nanoscale materials,
particularly as material properties (surface energy, conductivity etc.) can be very different at the nanoscale
than at the bulk. However, the patterning of organic bioelectronic materials is often not achievable using
conventional fabrication techniques, especially on soft, biocompatible substrates. Nonconventional
nanofabrication strategies are required. Dip-pen nanolithography is a nanofabrication technique which uses
the nanoscale tip of an atomic force microscope to direct-write functional inks. Over the past decade, the
technique has evolved as uniquely capable in the realm of bio-nanofabrication, with the capability to deposit
both biomolecules and electrode materials. This review highlights this new tool for fabricating nanoscale
bioelectronic devices, and for enabling heretofore unrealised experiments in the response of living cells to
tailored nano-environments. We firstly introduce bioelectronics, followed by a survey of different lithography
methods and their use to achieve paradigmic bioelectronic architectures. We then focus on dip-pen
nanolithography, highlighting the range of bioelectronic materials and biomolecules which can be deposited
using the technique, as well as its demonstrated use as a lithography tool in nano-biology. We discuss the
progress made towards upscaling the DPN technology towards larger areas, in particular via the polymer pen
approach.
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Nano-bioelectronics via dip-pen nanolithography 
C.D. O’Connell, M.J. Higgins, S.E. Moulton and G.G. Wallace* 
The emerging field of nano-biology is borne from advances in our ability to control the 
structure of materials on finer and finer length-scales, coupled with an increased 
appreciation of the sensitivity of living cells to nanoscale topographical, chemical and 
mechanical cues. As we envisage and prototype nanostructured bioelectronic devices there is 
a crucial need to understand how cells feel and respond to nanoscale materials, particularly 
as material properties (surface energy, conductivity etc.) can be very different at the 
nanoscale than at the bulk. However, the patterning of organic bioelectronic materials is 
often not achievable using conventional fabrication techniques, especially on soft, 
biocompatible substrates. Nonconventional nanofabrication strategies are required. Dip-pen 
nanolithography is a nanofabrication technique which uses the nanoscale tip of an atomic 
force microscope to direct-write functional inks. Over the past decade, the technique has 
evolved as uniquely capable in the realm of bio-nanofabrication, with the capability to 
deposit both biomolecules and electrode materials. This review highlights this new tool for 
fabricating nanoscale bioelectronic devices, and for enabling heretofore unrealised 
experiments in the response of living cells to tailored nano-environments. We firstly 
introduce bioelectronics, followed by a survey of different lithography methods and their use 
to achieve paradigmic bioelectronic architectures. We then focus on dip-pen 
nanolithography, highlighting the range of bioelectronic materials and biomolecules which 
can be deposited using the technique, as well as its demonstrated use as a lithography tool in 
nano-biology. We discuss the progress made towards upscaling the DPN technology towards 
larger areas, in particular via the polymer pen approach. 
 
Introduction 
Medical bioelectronic (or ‘bionic’) devices restore human 
function by interfacing electrical technology with the body.1 
Proven treatments include the Cochlear Implant (or “bionic 
ear”) which has restored useful hearing to hundreds of 
thousands of patients with profound deafness,2 and the deep 
brain stimulator, which has provided significant relief to 
sufferers of Parkinson’s disease and chronic pain.3 Many other 
devices are currently in development, such as implants to 
restore vision,4 to restore limb movement5 and as a means to 
control epileptic seizures.6 In recent years, the use of electrical 
stimuli to encourage and direct regrowth of damaged tissue has 
also been explored.7–10 The functional interface between any 
bionic device and the body is at the electrode, which locally 
stimulates electroactive tissue.11  
Current bionic devices use electrodes with geometrical areas of 
~mm2, where each electrode addresses thousands of cells. The 
performance of many bionic devices, particularly those 
designed to restore sensory function, could be greatly improved 
by fabricating arrays of many smaller electrodes, with each 
electrode targeting fewer cells.12 Figure 1 compares a 
conventional cochlear implant with macro-scale platinum ring 
electrodes with a high density array implant as fabricated by 
Allitt et al., 2011. The high density array resulted in less 
activity at nonspecific frequency regions in rat brains and 
produced significantly lower thresholds and larger dynamic 
ranges than the platinum ring electrode array.12  
 
Figure 1: (A) The electrode array of a conventional cochlear implant consists of a  
platinum ring electrodes around a polydimethylsiloxane (PDMS) shank. (The 
figure shows a model fabricated for implantation into a rat.) (B) High density 
electrode array (HDA) of 32 iridium activated stimulation sites along a polyimide 
shank. The HDA resulted in less activity at nonspecific frequency regions of the 
inferior colliculus than the platinum ring array. The HDA also produced 
significantly lower thresholds and larger dynamic ranges.12 [Reprinted from 
Hearing Research, 287/1-2, Allitt et al., Copyright 2012, with permission from 
Elsevier.] 
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Microelectrode arrays of 100 µm diameter have been used to 
monitor neuronal cell activity in vitro for over thirty years.13 
Ideally, however, electrodes would interface with individual 
cells (cell body <30 µm diameter), or even individual axons 
(cross-section <500 nm). This goal of electrode miniaturization 
presents new challenges on several levels. On one hand, the 
choice of material must be informed by the scaling of relevant 
properties as the electrode area is decreased. For example, as a 
gold or platinum electrode is shrunk down, the poor charge 
injection capacity of noble metals becomes a limiting factor.14 
On the contrary, novel materials may show improved 
performance at smaller scales; shrinking a conducting polymer 
electrode can increase the surface/volume ratio resulting in a 
relative increase in redox switching speeds.15 On the biological 
side, the interaction of cells with micron- and nano-scale 
features must be understood. Research over the past decade has 
confirmed that living cells feel and respond to topographical 
and chemical patterns with dimensions on the order of tens of 
nanometres.16–18 An inability to create structures of novel 
materials at nanometre lengthscales will ultimately hamper 
development in both materials and understanding of the cell-
material interface. The design of bionic devices with structure 
on the nano-scale constitutes the merging of bionics with 
nanotechnology, heralding the advent of ‘nanobionics’.19,20 
Others have highlighted several emerging technologies for 
fabricating model substrates with predesigned, 
nanodimensional architectures.21 This review highlights AFM 
printing, also known as dip-pen nanolithography (DPN), as a 
unique enabling tool for nano-scale bioelectronics and biology. 
Though we focus on conducting materials, we also touch on the 
capability of the technique to create nanoscale structures from 
biomaterials and hydrogels, and incorporating tailored 
patterning of functional groups, proteins, and cell-adhesion 
molecules. The technique has enabled the design of new 
experiments to answer fundamental questions in nanoscience 
and fundamental cell biology which were previously 
unanswerable. 
Nanofabrication for bioelectronics 
We begin with an introduction to nanofabrication, and a brief 
perspective on how traditional nanofabrication techniques have 
been used to create bioelectronic architectures. 
Nanofabrication has been defined as the process of making 
functional structures with arbitrary patterns having minimum 
feature size less than 100 nm in at least two spatial 
dimensions.22 Recent reviews of the latest developments in 
nanofabrication can be found in the literature.22–24  
The fabrication of nanostructured bioelectronic devices poses a 
number of unique challenges. Recent work has highlighted how 
an artificial biomaterial must be as soft as the tissue with which 
it is integrated.25 A nanostructure which emulates the extra-
cellular matrix is also desirable.26 Additionally, the device may 
be loaded with drugs for the controlled release of anti-
inflammatories or growth factors.27,28 Future devices are 
envisaged to be laced with chemo-attractants to encourage 
interface with specific cell types. Fabrication of such devices 
will require structure on a hierarchy of scales from macro-, to 
micro- to nano-. It is unlikely that any one fabrication strategy 
will meet all of these requirements. We focus here on the 
fabrication of nano-scale elements only. 
Photolithography 
The micro-processor has been described as the most complex 
device ever manufactured.29 The drive to keep pace with 
Moore’s law of periodically doubling transistor density has 
fuelled investment in ever more highly sophisticated 
photolithography systems over six decades.30 The resolution of 
the most advanced photolithography facilities is currently less 
than 20 nm, at least for inorganic semiconductors and metals.31 
The main limitation of high-end photolithography is its 
prohibitive expense for most applications. The capabilities 
available to most bioelectronics research laboratories are 
relatively unsophisticated and operate on the micro-scale.  
The basic procedure of photolithography involves coating a 
substrate with a thin layer of photoresist and exposing it to UV 
light through a patterned mask. The UV light effects a chemical 
change in the photoresist which changes its solubility in a 
developer solution. Selective removal of the pattern exposes the 
substrate to further processing steps. 
Photolithography has been used to fabricate high-resolution 
semiconductor devices for investigating the electrode interface 
at a single cell level. The Fromherz group at the Max Planck 
Institute for Biochemistry in Munich have been pioneers in this 
field.32 For example, Figure 2A shows a hippocampal neuron 
cell cultured on an electrolyte-oxide-silicon (EOS) field-effect 
transistor, and Figure 2B shows a schematic cross section of the 
neuron on transistor with blow-up of the contact area.33 Signal 
transduction occurs via current in the cell membrane (flowing 
during an action potential) creating an extracellular voltage in 
the cleft and thus modulating the source–drain current. 
Photolithography has also been used to fabricate arrays of 
individually addressable 2 µm diameter electrodes for the 
localized stimulation of neurons with sub-cellular resolution. 
Figure 2C shows a scanning electron micrograph of a primary 
hippocampal neuron (3DIV) on top of such a micro-electrode 
array chip.34 
2 | J. Name., 2012, 00, 1-3  
Journal Name ARTICLE 
 
Figure 2: High density electrode arrays fabricated by photolithography. (A) 
Scanning electron micrograph (colorised) of a hippocampal neuron cultured on 
an electrolyte-oxide-silicon (EOS) field-effect transistor and (B) schematic cross 
section of a neuron on a buried-channel field-effect transistor with blow-up of 
the contact area. [Reprinted from reference33 with permission from John Wiley 
and Sons.] (C) Scanning electron micrograph of a primary hippocampal neuron 
(3DIV) on top of a micro-electrode array chip (TiN coated tungsten electrodes in 
SiO2). Scale bar 5 µm. [Reprinted from reference
34 with permission from 
Elsevier.] (D) A high density array of 64 organic electrochemical transistors 
(OECTs). The transistors were composed of a 6 µm long poly(3,4-
ethylenedioxythiophene):poly(styrene sulfonate) channel contacted by gold 
electrodes.35 (E) The inset shows a magnified view of an individual OECT in the 
array, and (F) shows a schematic of the photolithography process. [(D-F) 
reprinted with permission from reference35 AIP Publishing LLC.] 
Although highly successful for fabricating devices from metals 
and crystalline semiconductors, photolithography processes are 
usually tailored to specific materials and harsh developer 
solutions may be incompatible with the non-conventional 
materials (such as soft, organic conductors) ear-marked for 
bionic applications.20 Novel processes are being developed to 
extend photolithography to organic materials. For example, the 
Malliaras group at the Ecole des Mines de Saint Etienne 
(formerly Cornell University) has shown how organic 
electronic devices can be fabricated through a parylene lift-off 
approach.36 The group have fabricated a range of devices to 
interface with living cells, in particular organic electrochemical 
transistors capable of detecting neurotransmitter release from 
single neurons37 and flexible, highly conformal devices for in 
vivo recording.38 Figure 2D shows a high density array of 64 
organic electrochemical transistors (OECTs) fabricated by the 
Malliaras group. The transistors were composed of a 6 µm long 
poly(3,4-ethylenedioxythiophene):poly(styrene sulfonate) 
channel contacted by gold electrodes.35 Though fabrication of 
organic electronic devices in this manner is very promising, at 
present the feature size is limited by the lift-off process at >1 
µm.36 
The technique of deep reactive ion etching (DRIE), is related to 
photolithography as it involves building a structure using a 
succession of masking steps. The patterns are defined by 
excavating trenches using a plasma etch however, rather than 
light-activated chemistry. The trenches are then filled (e.g. 
electrochemically) to form electrodes. This technique has been 
explored by the Wise group at the University of Michigan to 
fabricate high density cochlear electrodes and as well as 
cortical electrode arrays capable of single-unit recording.39,40  
Scanning beam lithography 
Scanning beam lithography (SBL) is a direct-write technique 
where a spot of a tightly focused beam is used to generate a 
pattern by either the selective removal of material or the 
selective deposition of a species. SBL is very slow (requiring 
up to 24 hours per cm2 for 20 nm scale features)22 but its high 
resolution and pattern fidelity make it a critical technology for 
the fabrication of masks for photolithography. SBL has also 
been used in niche research applications in bioelectronics.  
Figure 3A shows an array of nanowire transistors fabricated by 
the Lieber group at Harvard for their pioneering work in 
interfacing with neuron cells. The group succeeded in 
interfacing a single axon with a linear array of 50 SBL 
fabricated nanowire devices and thus monitor the propagation 
of an action potential 41 
Micro- and nano-contact printing 
The contact printing technique uses a patterned elastomeric 
stamp (typically PDMS) to transfer molecules to a substrate, 
typically via the formation of covalent bonds (e.g. self-
assembled alkanethiols on gold).42,43 Resolution is determined 
by the feature size of the stamp. Although typically used to 
generate micron-scale features, sub 100 nm resolution has been 
demonstrated.44 Limitations to feature size arise from the 
fidelity of the molding process used to create the stamp, the 
properties of the stamp material (e.g. ability to retain nanoscale 
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features) and distortion of the stamp while in contact with the 
surface.22  
The major advantage of contact printing is its low cost.23 The 
technique has been widely adopted by the biomedical research 
community for applications such as; patterning ECM proteins 
for controlling cellular adhesion,45 fabricating model substrates 
to study cellular biomechanics46 and for creating bio-molecular 
gradients.47 Figure 3B shows a biomolecule array generated by 
µCP for an in vitro study of cellular spreading as a function of 
ECM geometry. B16 (murine myeloma) cells were cultured on 
substrata patterned with different geometrical arrangements of 
the cell adhesion protein fibronectin. The degree of spreading 
was found to be dependent on spacing of the fibronectin 
features.48 
 
Figure 3: Fabrication by scanning beam lithography (SBL), micro-contact printing 
(µCP) and electrohydrodynamic jet (e-jet) printing. (A) SBL was used to fabricate 
a linear array of fifty nanowire (NW) transistors. Axon growth was direct along 
the NW junctions by patterning poly-L-lysine. The array of transistors used to 
follow the propagation of an action potential along the axon.[From reference41, 
reprinted with permission from AAAS.] (B) The images show B16 (murine 
myeloma) cells cultured on fibronectin substrata as patterned by µCP and 
labelled for fibronectin (red) and actin (green). The degree of spreading was 
found to be dependent on spacing of the fibronectin features. [Reprinted from 
the Journal of Cell Science48 with permission from the Company of Biologists 
Ltd.] (C) High resolution liquid deposition by e-jet printing. Optical micrograph of 
a portrait of the ancient scholar, Hypatia, printed using a polyurethane ink and a 
500-nm-internal-diameter nozzle. The inset shows an AFM image of the printed 
dots.[Reprinted by permission from Macmillan Publishers Ltd, reference49 
copyright 2007.]   
Jet printing 
Although ink-jet printing (IJP) was initially developed for the 
publishing industry, it has been adopted as an important and 
versatile technique for direct-write deposition of many 
functional materials.50 One unique prospect of IJP is 
incorporation of living cells within the ink, leading to the 
possibility of ‘bio-fabricating’ structures composed of both 
material and living components.51,52 IJP is ostensibly a micro-
scale fabrication technique, with a lower limit of droplet size in 
the pico-litre range, corresponding to resolution on the order of 
~10 um.  
A technique related to IJP, known as electrohydrodynamic jet 
printing (e-JP) has been recently devised which can jet femto-
litre  and even atto-litre volumes, corresponding to droplets 
with diameter on the ~200 nm scale.49,53 Resolution is 
dependent on liquid properties, substrate wettability and the 
diameter of the jet nozzle. e-JP is promising, however it is 
limited in that a conductive substrate must be used. Figure 3C 
shows a pattern e-jet printed using a polyurethane ink and a 
500-nm-internal-diameter nozzle. Individual dots have a 
diameter of ~490 nm.49   
Scanning Probe Lithography 
Scanning probe microscopes (SPMs) are a family of tools 
which use a physical probe, usually a tip with nanoscale 
sharpness, to scan back and forth and make images of 
nanoscale surfaces. Though primarily tools for characterisation, 
SPMs been used to fabricate many paradigmic nanostructures 
not achievable by other means, from patterns of individual 
positioning of xenon atoms,54 to the smallest field effect 
transistor.55   
The atomic force microscope (AFM) in particular has borne a 
rich suite of fabrication tools utilising the precise delivery of 
mechanical forces, thermal energy, electrical bias or materials 
deposition. 56–60. For a recent review of advanced scanning 
probe lithography (SPL) techniques, see this reference.61  
The simplest form of AFM lithography is to use the AFM tip 
literally as a nanoscale ‘pick’ or ‘shovel’ to scratch or cut into a 
substrate. The technique has been used to ‘nanomachine’ gold 
nano-wires,56 and to create electronic devices from 
semiconductors such as gallium arsinide.57 Thermomechanical 
AFM lithography is a variant where the probes are heated to aid 
indentation of soft polymers.62 This technique is exemplified by 
IBM’s Millipede device, which was equipped with an array of 
1064 individually addressable, locally heated probes, allowing 
for read-write-rewrite capabilities.63  
In AFM nanografting, nanoscale regions of a self-assembled 
organic layer are shaved away by the AFM tip and a second 
molecule adsorbs to fill in the pattern with resolution 
approaching the sharpness of the tip (~10 nm), see Figure 4A.64 
Besides secondary SAM molecules, both proteins65 and 
nanoparticles66 have been nanografted.  
In local oxidation nanolithography (LON) an electric bias is 
applied between the tip and substrate, inducing ionic 
dissociation of the water meniscus between tip and sample, and 
forcing a downward acceleration of negatively charged species 
(OH-, O-) towards the surface. In the case of a silicon substrate, 
the OH- anions combine with holes at the surface resulting in 
the localised growth of SiO2. The technique has been used to 
push the fabrication limits of devices such as metal-oxide-
semiconductors via nanoscale definition of the local oxide 
growth.58,59 Figure 4B shows, at left, a generic schematic of the 
LON technique and, at right, a nanoscale oxide structure 
fabricated by LON for fundamental quantum mechanical 
experiments in ring geometries.67 Some efforts at upscaling the 
technique have been made, for example the Quate group at 
Stanford have used arrays of up to 50 cantilevers to effect 
centimetre scale lithography.68 
The AFM lithography techniques described above generate a 
pattern by delivering energy to selectively remove or modify a 
pre-existing substrate.  The innovation to use an AFM tip to 
deliver material opened up totally new possibilities for AFM 
lithography.69 In a concept known as “Nano-fountain probe” or 
“liquid nanodispensing”, material is delivered a nanochannel 
through the AFM tip.70–72 This approach has demonstrated 
versatility through the printing of gold colloids,73 DNA74, and 
proteins.75 The design has allowed for some unique 
applications, for example, the injection of single cells with 
nanoparticles (Figure 6C).60 
An impressive innovation in recent years has been the advent of 
lithography using modified scanning ion conductance 
microscopes. Conducting polymer nanostructures can be 
synthesised in situ at the apex of a nanopipette.76 In another 
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approach, freestanding metal electrodes have been fabricated 
via the meniscus-confined electrodeposition of copper or 
platinum (Figure 4D).77 
 
Figure 4: Selected scanning probe lithography strategies: (A) AFM nanoshaving 
involves the selective removal of an organic SAM from a metal or oxide surface 
using mechanical force applied by an AFM tip. When nanoshaving is performed 
in a solution of secondary SAM molecules, the shaved regions are ‘nanografted’ 
with the secondary SAM. [Adapted with permission from Liu et al, Accounts of 
Chemical Research 33, 457–466. Copyright (2000) American Chemical Society.]78 
(B) [Left] In local oxidation nanolithography (LON), the applied field induces ionic 
dissociation of the water meniscus between tip and sample and the oxidative 
OH- anions migrate to the substrate and react with it to form localised oxide 
structures. [Schematic reproduced from reference 79 with permission from The 
Royal Society of Chemistry.] [Right] LON has been used to create novel 
nanoelectronic architectures by patterning local oxide on semiconductors 
[Reprinted by permission from Macmillan Publishers Ltd: Nature 413, 822–5, 
copyright (2001).]67 (C) The nanofountain probe (NFP) incorporates microfluidic 
channels inside the cantilever to deliver liquid or molecular ink from a reservoir 
to the writing tip. The design allows for not only deposition of ink on substrates, 
but also the injection of ink (in this case a nanoparticle solution) into living cells. 
[Copyright © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. Reproduced 
with permission,]60 (D) The nanopippete of a scanning ion conductance 
microscope can be used to fabricate free-standing metal electrodes via 
electrodeposition confined to the contact meniscus formed between the pipette 
and the substrate. [From reference77, reprinted with permission from AAAS.] 
Dip-pen nanolithography 
Dip-pen nanolithography (DPN) is one further candidate 
technology for fabricating novel substrates tailored at the nano-
metre scale. DPN is a constructive lithography technique which 
uses an atomic force microscope (AFM) tip to deposit 
molecules or materials in a direct-write fashion.80 Key to the 
technique is the fact the AFM cantilever is ‘dipped’ into the ink 
and thus coated—an approach that extends versatility by 
avoiding the clogging of nanofluidic channels. It is of particular 
interest to the bioelectronics community as many of the 
essential ingredients of prospective bioelectronic devices can be 
printed: including metals,81–85 insulators86 and conducting 
polymers.87–89 DPN also enables the nanoscale patterning of 
biomolecule cues through the deposition of DNA and 
proteins.90,91 The capability to ‘multiplex’ many different 
biomolecules within a  subcellular area allows for the creation 
of complex substrates tailored with biomolecules on the 
nanometre scale, with huge implications for both fundamental 
and applied cell biology.92 The non-destructive nature of DPN 
means it is compatible with many substrates including soft, 
flexible polymers93 and even biological tissue.94 Although AFM 
based lithography has traditionally been regarded as a serial, 
and therefore slow fabrication technique, great strides have 
been made in parallelization of DPN; first to “massively 
parallel” 55000 cantilever arrays,95 and more recently using 
polymer pen lithography (PPL) arrays capable of 
simultaneously printing up to 11 million patterns over cm2 
areas.96 DPN is already finding use as a tool for fabricating 
novel nano-patterned cell-growth platforms for fundamental 
cell-biology studies.97–101  
Particularly unique is the ability of DPN to manipulate minute 
quantities of liquids.85,91,93,102 Liquid inks are interesting in the 
biomedical field for their ability to operate as ‘universal’ carrier 
matrices for biomolecules.91 The patterning of hydrogels is 
fascinating as it may also provide a novel means to tailor a 
heterogeneous soft material interface at the nano-scale.102 
Liquid deposition patterning is usually not substrate specific 
and so is versatile enough for printing on a variety of hard and 
soft substrates.93 The development of liquid ink DPN may also 
by accelerated by the adaption of many hundreds of strategies 
already developed for other liquid printing techniques, such as 
ink jet printing.50  
In the paradigmic DPN system, alkanethiol molecules are 
adsorbed onto an AFM tip. When the tip is brought into contact 
with a gold surface, a water meniscus is formed via capillary 
condensation and the alkanethiol molecules diffuse through the 
meniscus and bond to the surface.80 Most DPN strategies 
prescribe to this mechanism of diffusive molecular transport. 
Viscous liquid inks are deposited via a different mechanism, 
critically dependent on the growth of the ink meniscus itself,103 
and can be subject to hydrodynamic effects which can impact 
on the uniformity of deposition.104  
Bioelectronic Materials Deposited by AFM Nanoprinting 
A range of methodologies have been developed over the past 
decade to print metal features via DPN (see Table 4-1 for a 
summary). Many of the DPN approaches concern the patterning 
of metal nanoparticles, in particular functionalised Au 
nanoparticles, for sensing or bio-recognition 
applications.66,73,105–107 Although interesting for the varied 
approaches used to effect ink-transfer (e.g. ink-substrate 
hyrophobicity, nanografting etc), the presence of insulating 
capping agents precludes many of these strategies from 
generating conductive lines. One nanoparticle based 
methodology did target the deposition of conductive traces by 
including silver nanoparticles in a glycerol thickened ink 
formulation.84,85 A relatively high conductivity was achieved 
(3x104 S cm-1) using an annealing temperature of 150 °C.  
The surface activated in-situ redox approach utilises opportune 
surface chemistry to effect reduction of a metal precursor ink 
upon deposition.108,109  In-situ reduction has been achieved for 
Au and Pd on bare Si (from which the oxide layer was removed 
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by hydrogen fluoride) and Ge substrates. Although extending 
this approach to flexible materials may be possible, it would 
require pre-functionalising the substrate with a suitable electron 
donating ligand. 
Table 4-1: Selected DPN metal printing studies. 
Met Sub Method 
Res (nm) 
Dot Line 
Direct deposition of NPs 
Au SiOx Au NPs; hydrophobic modified105 50 - 
Au Au Nanografting on thiolated Au66 - 150 
Au mica Functionalised NPs, DPN in solution106 - 40 
Au -NH2/ SiOx 
Nanofountain pen, functionalised 
NPs73 200 - 
Ag SiOx, Kapton Ag NP ink, 150 °C cure
84,85 - 500 
Thermal DPN 
In SiOx Heated tip, 250-500 °C82 - 50 
Surface activated in situ redox 
Au Si (HF treat) 
HAuCl4 in situ redox on 
elemental Si108 <100 <100 




H2PtCl6 reduction with 4V bias 
applied to tip81 - 30 
Au OTS/ SiOx 
Electrograft Au NPs on OTS 
SAM110 - 50 
Chemically directed assembly (CDA) of NPs 
Au Au Au NPs on amine terminated patterns111 - <100 
Seeded growth 
Au Ag/ SiOx 
Thiol pattern and etch Ag, reduce 
HAuCl4 on Ag112 
1000 - 
Ag Au Electroplate Ag on thiol patterned Au113 190 170 
Au SiOx +12V bias, Au NPs, seed growth of HAuCl4114 
- 250 
Au, Ag SiOx Print NP tagged enzyme HAuCl4 growth solution115 - 500 
Wet etching a metal coating 
Au SiOx DPN print ODT resist and wet etch83 ~50 ~50 
Au SiOx Polymer pen MHA resist and wet etch96 ~50 ~50 
Electroless deposition 
Au, Pt HMDS/ SiOx 
Print metal precursor loaded 
block-copolymer micelles, O2 or 







Thermal DPN deposition of 
HAuCl4, annealing at 270°C. 117 
50 55 
Reduction of a metal precursor within the contact water 
meniscus by applying a bias between pen and substrate (i.e. 
electrochemical DPN) has been used to nanopattern both Pt81 
and Au110 at line resolution down to 30 nm.  This approach, 
however, necessitates a conducting or semi-conducting 
substrate, limiting its utility on flexible polymeric materials. 
The seeded growth approach uses the metal pattern as a seed 
site for the reduction of a metal precursor in a post-treatment 
growth step.112–115  The idea is interesting as a augmentation to 
other printing methods (e.g. to improve pattern continuity),114 
but is not a printing methodology in itself. 
Nanopatterning a thiol resist against the wet-etch of a metal 
coating is the most popular method in the literature for 
generating conductive metal patterns by DPN.96,113,118  This 
method can achieve micro- or nanoscale resolution (<50 nm) 
and upscalability to millions of features over cm2 areas (via 
polymer pen lithography).96  The method also does not 
compromise electrical properties as the pattern will retain the 
conductivity of the thermally evaporated metal thin film. Most 
of the work thus far has focused on gold, although both Ag and 
Pd patterning have been demonstrated.119 Extending this 
approach to Pt presents significant challenges, however.  The 
only known etchant for Pt metal is the highly corrosive aqua 
regia (a mixture of concentrated nitric and hydrochloric acids in 
a 1:3 ratio). The effectiveness of a thiol SAM to protect against 
an aqua regia etch is yet to be demonstrated. 
Recently, the Mirkin group adapted ‘block copolymer 
lithography’ for both DPN and PPL techniques.116 Their ink 
was based on block-copolymer micelles loaded with metal ions 
(AuCl4- or HPtCl6-). After printing of the micellar ink, an 
oxygen plasma treatment effected reduction of the metal ions 
by a hydrocarbon oxidation mechanism.  Although a landmark 
study, as the features generated (~4.8 nm) were smaller than the 
radius of the pen used to print them (~15 nm), this approach 
was limited to patterning of single dots, and not continuous 
lines.  The micellar vehicles define the minimum proximal 
distance between features at about 500 nm. 
A final approach is the electroless deposition of metal 
precursors is to DPN print a metal precursor salt and 
subsequently reduce the salt via heat treatment in situ. THis 
strategy has been used to fabricate gold patterns using a locally 
heated DPN tip.117 Both dots and lines were deposited on 
various substrates, however a reduction temperature of 270°C 
was required, which may not be amenable to polymeric 
substrates. Our group have since extended the electroless 
deposition approach to print nanoscale platinum features on 
sensitive substrates by using a mild plasma treatment to effect 
reduction of the printed precursor.120 
One of the first application-orientated DPN studies exploited 
patterned alkanethiols as etch resists to form gold and silicon 
nanostructures, highlighting the potential of DPN in the 
fabrication of nanoelectronics with <20 nm resolution and 
arbitrary pattern design.83 This methodology has been 
successfully upscaled to polymer pen lithography.96 In working 
devices, nano-scale electrodes are often addressed by macro-
scale electrodes made using conventional photolithography. 
Some methods for achieving registry between DPN and micro-
fabricated structures have been described.121 One highlight has 
been the definition of electrical contacts to single graphene 
flakes under ambient conditions.122 Another potential 
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application which has been cited is the inspection and repair of 
defects in prefabricated photomasks123 and in integrated 
circuits.85  
DPN of conducting polymers has been achieved by several 
methods including; electrostatically driven transport,89 
electrochemical DPN,87 in situ polymerization88 and direct 
writing of soluble CP.124 The approaches are outlined in Table 
3-1. Such approaches have been used to create organic 
electronic devices exhibting fast switching speeds.124  The 
capability of liquid ink deposition to fabricate conducting 
polymer electrodes on a variety of flexible substrates shows 
promise for pushing the limits of organic bioelectronics 
devices. 93,125,126  
Table 3-2: Selected DPN conducting polymer printing studies. 
Poly-
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PEDOT SiO2 Electrochemical DPN87 - 50 
Ppy SiO2 
In situ polymerization of 
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PSS SiO2 
Meniscus transport of soluble 













Deposition of oxidant and vapour 




SiO2, Liquid ink deposition
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Figure 5: DPN printed conducting polymers approaching nanoscale resolution. 
(A) PEDOT:PSS features fabricated via DPN liquid ink deposition. On left is an 
AFM topographical image of an array of uniform PEDOT:PSS dots. On right is a 
3D rendered AFM topography image of a single PEDOT:PSS feature. 
[Reproduced from Wagner et al126, Copyright Elsevier 2012 (permissions 
pending)] (B) PEDOT PSS lines (300 nm width) bridging two metal electrodes 
and forming an NO gas sensor. On left is a 2D AFM image of the patterned 
lines. On right is a 3D rendered AFM topography  image of the same line 
features. [Reprinted from reference124 with permission from Elsevier.] 
Nano-biology Applications 
As DPN can operate in an  ambient environment, and with little 
or no post-treatment, fragile biological structures such as 
DNA128 and proteins129 could also be printed at nanoscale 
resolution while retaining their native structure. A biomolecule 
carrier ink has been developed for versatile printing of proteins 
or oligonucleotides with consistent deposition rates.91 The 
possibility of patterning hydrogels and lipids at nanoscale 
dimensions also has numerous potential applications in the 
patterning of a soft localised cellular nanoenvironment.92  DPN 
has also been used to pattern virus particles,130 and even a 
bacterial ‘ink’ has been developed.131  The dozens of methods 
to DPN print biomolecules, by both direct and indirect 
methods, were reviewed in 2011.132 
BIOMOLECULE NANOARRAYS One of the applications for which 
DPN seems most immediately suited are in the generation of 
biomolecule nanoarrays for high through-put screening assays 
in proteomics, genomics and drug development.69 The powerful 
potential of nanoarrays in biomedicine is illustrated by an 
example outlined by Mirkin:123 A DNA array capable of 
identifying any known sequence would require 4 x 1017 features 
and so a micro-array with 50 µm features would be 
approximately the size of a tennis court. A nanoarray with 50 
nm features would be only ~1 cm2, making such a chip 
practical in real world applications. 
The first proof of concept of a DPN printed nanoarray used for 
diagnostic purposes was demonstrated by the Mirkin group in 
2004 (Figure 10A).133 Nanoarrays of antibodies against the 
HIV-1 p24 antigen (anti-p24) were created by electrostatic 
binding to MHA nanopatterns. HIV-1 p24 antigen in plasma 
obtained from HIV-1-infected human patients was hybridized 
to the antibody array in situ. Detection of the hybridization was 
via height change (from 6.4 nm to 8.7 nm) as measured by 
AFM.  A gold antibody-functionalized nanoparticle probe was 
also used for signal enhancement (height change 20 nm).  
Although a slow and laborious process in this form, the assay 
achieved a limit of detection of 0.025 pg per ml, exceeding that 
of conventional enzyme-linked immunosorbent assay (ELISA)- 
based immunoassays.  
Nanoarrays are also important as models for fundamental 
studies of biomolecular interactions, and have huge potential 
when coupled with strategies of AFM force measurements. 
DPN printed nanoarrays of αvβ3 integrins or BSA were probed 
by an AFM tip functionalised with vitronectin.134 Increased 
adhesion forces arising from specific interactions could 
distinguish integrin from BSA. Although still in its infancy, this 
methodology may lead to a robust model system of studying the 
interaction force of pairs of biomolecules as a function of 
solution condition (pH, ionic strength) and conformation, 
especially with the advent of strategies to generate single-
molecule protein arrays.135  
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Figure 6: (A)  Schematic of the immunoassay format used to detect HIV-1 p24 
antigen with anti-p24 antibody nanoarray. The anti-p24 antiobody was 
immobilized on DPN printed MHA patterns by an electrostatic interaction. 
Binding of the p24 antigen produced an increase in height of the nanoarray as 
monitored by AFM. The increased height signal could be amplified using anti-
p24 modified gold nanoparticles.  [Reprinted from Lee et al., 2004133, Copyright 
2004 American Chemical Society.] ((B) CV1 monkey kidney cells adhering to 
nanoarrays of rSV5-EGFP virus engineered to express green fluorescent protein 
(GFP). Infection of the cells by the virus could be monitored by the increased 
GFP fluorescence over time. [Reprinted with permission from Vega et al.136 
Copyright 2007, John Wiley and Sons]  
INFECTIVITY STUDIES The Mirkin group demonstrated the 
capability of DPN to generate arrays of single virus particles in 
an active state.130 The immobilized virus particles were capable 
of infecting living cells cultured on the arrays.136 Through the 
use of green fluorescent protein expressing virus particles, an 
assay was developed to follow the infectivity process on 
nanoarrays using fluorescence (Figure 10B). Thus the 
systematic examination of single-cell infectivity with control of 
the density and spatial distribution of virus particles has been 
made possible. The direct write patterning of bacterial cells by 
DPN was also recently demonstrated, opening the door to 
similar infectivity studies at the bacterial level as well as 
possible applications in drug-delivery, biofilms and molecular 
motors.131 
NANOPATTERNED MODEL SUBSTRATES FOR FUNDAMENTAL IN 
VITRO CELL STUDIES An understanding of the processes of 
adhesion, migration, differentiation in artificial environments is 
crucial to the development of novel approaches to medicine 
such as tissue engineering137 and medical bionics.20 Model 
substrates presenting well defined patterns allow for the 
systematic study of the cell-material interface and have been 
important for elucidating the spatial and temporal mechanisms 
of these processes.138  
Since the 1990s SAMs of alkanethiolates on gold have been a 
prominent model substrate for fundamental in vitro cell 
studies.139 Key to their success as a model substrate is the 
simplicity of their preparation, and the diversity in choice of the 
presented groups. The ability to pattern these SAMs on the 
scale of single-cells using micro-contact printing42 lead to some 
seminal work in the control of cell-fate by purely geometric 
means.140 A generic protocol has become the method of choice 
for patterning cells:45 hydrophobic alkanethiols are generated 
on gold via micro-contact printing and remainder of the 
substrate is rendered biologically inert by immersion in a 
solution containing oligo(ethylene glycol) terminated 
alkanethiol. Hydrophobic alkanethiols permit the adsorption of 
ECM proteins, and cells only adhere to the patterned areas. 
Living cells are sensitive to nanoscale topographic and 
biomolecular patterns,16 though the mechanisms by which cells 
transduce signals from their microenvironment is poorly 
understood. DPN has allowed for the fabrication of model 
substrates at the nano-domain, allowing the study of geometric 
effects at a much finer scale than previously possible, that of 
individual focal adhesions. The differentiation of human 
mesenchymal stem-cells (MSC) differentiation was controlled 
via DPN nanopatterns of various functional groups without the 
use of differentiation media.99,100 The size of nanospots was 
optimized at 70 nm diameter corresponding to the diameter of 
cellular focal adhesion structures. MSC adhesion and 
phenotype was dependent on both the terminal functionality 
(amino, methyl, hydroxyl or carboxyl) and the pitch (140 to 
1000 nm) of the nanopatterns.  The nanopatterns were shown to 
influence the formation of focal adhesions through controlling 
specific integrin clustering, which can then be used to direct 
cellular response. 
Besides nanopatterning of surface chemistry, the capability of 
DPN to generate biomolecule nanoarrays is enabling the 
systematic study of biospecific interactions at the nanoscale. 
Nanoarrays of the cell-adhesion protein retronectin have been 
used to study the fundamental processes of cellular adhesion.141  
The adhesion of 3T3 mouse fibroblast cells on DPN generated 
nanoarrays of both linear and cyclic RGD cell adhesion 
peptides has also been studied.97 Cells were found to develop 
eight times more focal adhesions on the cyclic rather than the 
linear RGD patterns. Cell adhesion was also dependent on spot-
size and pitch of the nanoarrays. In a later work, the same group 
explored this effect further, studying how nanoarray geometry 
influences cell polarity orientation (Figure 11A).98 They found 
that 3T3 cells were polarized on asymmetric arrays, but not on 
symmetric arrays, of linear RGD peptide. In other work, 
microspots of fibronectin were also shown to define the 
morphology of 3T3 fibroblasts (Figure 11B).142 
A unique advantage of DPN is the capability to create high 
resolution patterns of multiple ink formulations over a 
subcellular area.  Figure 11C shows fluorescence micrographs 
of poly(ethylene glycol) dimethacrylateloaded hydrogel 
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features loaded with four different dyes printed as a multi-ink 
printing demonstration.92 Lenhert and Fuchs have printed lipids 
by DPN with the goal of generating biomimetic membrane 
patterns as model substrates for cell culture.143 They 
demonstrated the multi-plexed printing of lipids with lateral 
resolution down to 100 nm. By binding functional proteins to 
lipids containing either a nickel chelating headgroup or a 
biotinylated headgroup, they could demonstrate the selective 
adhesion and activation of T-cells.  In a related development, 
the Salaita group used patterns of a cationic polyelectrolyte to 
impede lipid diffusion and therefore control spatial organization 
of ligands in membranes and cells.144 
A particularly exciting outcome of biomolecule nanopatterning 
is the possibility of localized delivery of drugs to single cells. 
Figure 11D shows NIH 3T3 fibroblasts cultured on DPN 
printed microarrays locally delivering Calcein AM (green 
colored cells), Calcein Red AM (red colored cells) or DMSO 
(no color cells). Localized intake of the dyes is evidenced by 
the overlaid fluorescence image.145 This work highlights the 
potential for high-throughput, lab-on-a-chip drug screening 
assays, especially when complemented by advances in multi-
inking of large area, massively parallel arrays.146 
 
Figure 7: (A) Cellular response to a nanoscale arrangement of binding sites. 3T3 
mouse fibroblast cells adhering to symmetric (top) and asymmetric (bottom) 
nanoarrays of immobilized RGD linear peptide. The diffuse distribution of the 
Golgi surrounding the nucleus indicates that the cell on the symmetric 
nanoarray is not polarized, whereas the cell on the asymmetric array is 
polarized. [Adapted from Hoover et al.98 Copyright 2008 American Chemical 
Society:] (B) Controlling cellular morphology with subcellular protein patterns. 
Fluorescence microscopy of 3T3 fibroblasts attaching to DPN printed 
fibronectin patterns and spreading over time. At 2 h, cell morphology is 
defined by  the protein patterns. Scale bar = 20 µm. [Adapted with permission 
from Collins et al.142 Copyright 2011 Elsevier.] (C) Multi-ink pattern generation 
over sub-cellular areas. Fluorescence micrographs of poly(ethylene glycol) 
dimethacrylateloaded hydrogel features loaded with four different dyes— 
rhodamine/FITC (orange), rhodamine (red), Alexa347 (blue), and, FITC (green) 
[Reprinted from Stiles et al.92 copyright 2010 MacMillan Publishers Ltd] (D) 
Targeted drug delivery. NIH 3T3 fibroblasts cultured on DPN printed 
microarrays locally delivering Calcein AM (green colored cells), Calcein Red AM 
(red colored cells) or DMSO (no color cells). [Adapted from Collins et al 2012,145 
with permission from the Royal Society of Chemistry.]  
 
Upscaling DPN 
Early DPN experiments were considered very low throughput 
as they used only single pen or limited linear pen-arrays. The 
limitation of upscalability has been addressed by successive 
examples of increased parallelization;123 the 32 cantilever linear 
pen array was introduced in 2002,147 and the 55,000 cantilever 
2D ‘massively parallel’ pen array in 2006 (though whole wafers 
of 1.3 million pens were also fabricated as proof of concept).95  
Although they were commercialised, the pen arrays were 
fragile, expensive to fabricate and required a labour intensive 
levelling process.148  
Invention of polymer pen lithography 
The efforts toward parallelization culminated in 2008 with the 
invention of polymer pen lithography (PPL).96 PPL presented 
an elegant ‘cantilever-free’ solution to the problem of 
increasing pen density array using a PDMS stamp of thousands 
of nano-sharp pyramidal tips.  The PDMS stamp could 
fabricated using a Si mould, greatly simplifying the pen 
fabrication process, and reducing the material cost per ‘stamp’ 
to just $1.  PPL represented the convergence of large area but 
pattern specific soft-lithography with small area, direct write 
DPN.149   
In the past five years, significant advances have been made in 
improving the practicality of PPL. A clever solution to the 
multi-plexed inking of PPL stamps was found in using the 
silicon master (used to fabricate the stamp) as the ink-wells.  
Ink-jet printing was used to fill different ‘ink wells’ with 
different proteins.146  A method of levelling the stamp with the 
potential of automation was developed which uses the force 
applied by a non-levelled stamp on the substrate as the basis for 
a feedback loop.150 
An additional parameter to be considered with PPL is that, in 
contrast with DPN, feature size is force dependent.96 This can 
be advantageous as feature size can be controlled without 
relying on environmentally sensitive diffusion processes.151 
However, the deformation of the PDMS tips does place a 
resolution threshold on the technique.  The contamination of 
printed features with molecules of PDMS (a problem in soft-
lithography) is also left open. A recent development, dubbed 
‘hard-tip soft-spring’ lithography, addresses these issues by 
using a PDMS stamp capped in silicon oxide.152  
PPL has been used for the large area patterning of the cell 
adhesion protein fibronectin as a means to rapidly screen the 
influence of fibronectin feature size on the adhesion and 
differentiation of human mesenchymal stem cells (MSCs).101 
MSCs cultured on optimised nanopatterns of fibronectin 
differentiated towards osteogenic fates, even without media 
containing osteogenic-inducing chemical cues. 
An intriguing spin-off technology from PPL, dubbed ‘beam-pen 
lithography’ (BPL), has enabled a maskless, direct-write 
parallelization of photolithography.153 In BPL, 400 nm light is 
passed through nanoscopic apertures in the polymer pen tips, to 
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generate thousands of sub-wavelength (100 nm) spots.  Piezo-
electric manipulation of the polymer pen allows for generation 
of arbitrary photolithographic patterns.   
The progress in up-scaling the DPN technology over the past 
decade has been impressive. For example the printing time to 
deposit 1 billion features has decreased 5 orders of magnitude 
over three generations of DPN systems.149 
 ‘Active’ probe arrays 
Besides up-scalability, some limitations to DPN do remain. In 
particular, the major advances in parallelisation have utilized 
passive pen arrays.  Although millions of tips over multi cm2 
areas can engage in printing simultaneously, a passive pen array 
can only generate duplicates of a single design.  ‘Active’ 
parallel probe arrays consisting of individually addressable 
cantilevers have been demonstrated using both thermally 
activated and electrostatically activated probes.154,155 Such 
inventions could lead to a vast increase in the possible pattern 
complexity would be achieved, particularly if combined with 
multi-plexed printing. No active probe system for a 2D DPN 
probe array has been reported. However, IBM Zurich did 
demonstrate the actuation of individual cantilevers in a 
massively parallel arrangement during the development of their 
‘Millipede’ memory storage device.63 
 Summary and outlook 
In the past decade DPN has become increasingly recognized as 
a powerful tool for creating designer substrates using nano-
scale, molecular building blocks. The huge versatility afforded 
by the availability of hundreds of demonstrated ink-substrate 
systems has piqued the interest of researchers from a wide 
range of disciplines. The ability of DPN to deposit metal and 
organic conductors at nanoscales, and on a range of substrates, 
could prove important for bridging the world of bioelectronics 
with nanoscience.  
The impact of DPN on the biological sciences has grown. In 
recent years, several breakthroughs in understanding stem cell 
differentiation have been made possible using DPN nanoarrays. 
However, much of DPN’s potential is as yet untapped. In 
particular, the recent advances demonstrating multi-ink protein 
patterning over large areas have yet to be utilized to address 
long standing questions in fundamental cell biology, such as the 
complexities of how cell phenotype is influenced by multiple 
signaling proteins arrayed on a surface.  
The invention of polymer pen lithography has enabled the high 
resolution printing of DPN to be up-scaled to millions of 
simultaneous patterns in a cost-effective manner. Multi-plexed 
inking strategies have also been developed, but pattern 
complexity still remains restricted by limitations imposed by 
the passive probe design.  The greatest potential of DPN/PPL 
technology will be only unlocked when multi-inking strategies 
are married with individually addressable, massively parallel 
active pen arrays. A good understanding of the parameters 
affecting molecular ink transport has been compiled.  However, 
much further work is required to achieve a similar level of 
understanding for liquid ink deposition.  
There are as yet no examples of DPN being used to create 
standalone bioelectronic devices, yet it promises to have a 
significant impact when use in conjuction with more traditional 
techniques, as surveyed in the opening section of this review. 
The capability of DPN to deposit organic conductors and 
molecular coatings could be used, for example, to achieve 
localised augmentation and funcntionalisation of prefabricated 
electronics at nanoscales. 
Perhaps the most unique capability of DPN is its versatility in 
being able to deposit both biomolecules and conductors at room 
temperature and in an ambient environment. This opens the 
door to the possibility, as yet untapped, to fabricate integrated 
systems incorporating both biomolecule and conducting 
components. Conducting polymers containing biomolecules, 
and even red blood cells, as part of their matrix have already 
been synthesised.156,157 Using available technology, one can 
envision the use of DPN to create conducting polymer 
electrodes which could be nanopatterned (or even locally 
doped) with multiple biomolecules, or biomolecular gradients, 
at nano-scales. Patterned chemoattractants, for example, could 
be used to control the formation of 2D neuronal networks or 
neuromuscular junctions, or to study the fundamental processes 
of axon guidance.  
DPN, like other SPM based lithography tools, is in its element 
in a research setting. The technology provides a means to 
fabricate novel structures. We have highlighted capabilities 
such as the arbitrary patterning of individual 5 nm 
nanoparticles,116 or individual proteins,135 and the patterning of 
multiple different proteins within subcellular areas142 which are 
not achievable by other means. These tailored 
nanoenvironments, and others, will continue to justify DPN and 
PPL as enabling tools; using these techniques researchers can 
design new experiments and answer fundamental questions in 
bioelectronics and fundamental cell biology.   
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